SwanBio Therapeutics is a gene therapy company focused on delivering genetic medicines to patients with serious neurological diseases. Dr. Rachel Salzman co-founded SwanBio Therapeutics in 2017, after serving as the Chief Science Officer (CSO) of The Stop ALD Foundation since 2001. The Stop ALD Foundation is a non-profit Medical Research Organization dedicated to employing entrepreneurial…Read more